ȸ¿ø°¡ÀÔ | ¿¬¶ôó | »çÀÌÆ®¸Ê | English

      È¸»ç¼Ò°³ | ¸®Æ÷Æ® | Ä¿½ºÅÒ ¸®¼­Ä¡ | °í°´Áö¿ø


·Î±×ÀÎ

Ä«Å×°í¸®

À¯/¹«¼±Åë½Å

Àü±â/ÀüÀÚ

µðÁöÅбâ±â/¹Ìµð¾î/¹æ¼Û

Information Technology

¿¡³ÊÁö

»ý¸í°øÇÐ

È­ÇÐ/½Å¼ÒÀç

ÀÚµ¿Â÷

ȯ°æ

ÀϹݼҺñÀç

¸¶ÄÉÆÃ/±¤°í

±ÝÀ¶

°Ç¼³

±³Åë/¿î¼Û

¼ÒºñÀÚÁ¶»ç

¹æÀ§/Ç×°ø/¿ìÁÖ

½ÄÀ½·á

Áß°ø¾÷

±³À°

±â°è

¹«¿ª

½ºÆ÷Ã÷/·¹Àú

ÇØ¿î/Á¶¼±

ÆмÇ

Á¤ºÎ/Á¤Ã¥

°ø¿¹/±Í±Ý¼Ó

ÄÄÆÛ´Ï ÇÁ·ÎÆÄÀÏ

±âŸ»ê¾÷

 
ÇöÀçÀ§Ä¡ : HOME > ¸®Æ÷Æ® > È­ÇÐ/½Å¼ÒÀç > ³ª³ë
Nanotechnologies for Life Sciences and Healthcare Market
¹ßÇà»ç Nanoposts.com

¹ßÇàÀÏ 2007-10
ºÐ·® 170 pages
¼­ºñ½ºÇüÅ Report
ÆǸŰ¡°Ý

ÀμâÇϱâ
1 INTRODUCTION

1.1 Nanotechnology in Life Sciences and Healthcare
1.2 Key applications and market opportunity to 2015
1.3 Market for nanomaterials in life sciences and healthcare
1.3.1 Nanoscale biosensors and imaging
1.3.2 Nanocoatings on surfaces and implants
1.3.3 Nanoparticulate drug delivery
1.4 Key Players

2 KEY NANOTECHNOLOGIES

2.1 NANOPARTICLES

2.1.1 Market for nanoparticles
2.1.2 Key players
2.1.2.1 Manufacturers and End Users
2.1.2.2 Nanomaterials suppliers
2.1.2.3 Application manufacturers

2.2 NANOCAPSULES
2.2.1 Market for nanocapsules
2.2.2 Key players
2.2.2.1 Manufacturers and End Users
2.2.2.2 Nanomaterials suppliers
2.2.2.3 Application manufacturers
2.3 NANOPOROUS MATERIALS
2.3.1 Market for nanoporous materials
2.3.2 Key Players
2.3.2.1 Manufacturers and End Users
2.3.2.2 Nanomaterials suppliers
2.3.2.3 Application manufacturers

2.4 QUANTUM DOTS
2.4.1 Market for quantum dots
2.4.2 Key players
2.4.2.1 Manufacturers and End Users
2.4.2.2 Nanomaterials suppliers
2.4.2.3 Application manufacturers

2.5 NANOCOATINGS
2.5.1 Market for Nanocoatings
2.5.2 Key players
2.5.2.1 Manufacturers and End Users
2.5.2.2 Nanomaterials suppliers
2.5.2.3 Application manufacturers

3 TECHNOLOGY PROVIDERS

3.1 PHARMACEUTICALS: FORMULATION
3.1.1 Fluorescently encoded microparticles for multiple analysis and design of drug delivery
3.1.2 Pharmaceutical formulations of nanoparticulate systems
3.1.3 Formulation of pharmaceutical compounds at the nanoscale
3.1.4 Fluoropolymer materials platform for drug therapy
3.1.5 Nanotechnology to accelerate the chiral drug development process
3.1.6 DNA nanoparticle technologies to produce safe and effective DNA drugs
3.1.7 Cell based electrophysiology chip for the discovery of drugs for ion channel diseases
3.1.8 Drug profiling using smart materials
3.1.9 Nanoemulsions
3.1.10 Water-based materials using nanotechnology to enhance bioavailability and solubility of existing and new drugs
3.1.11 Supercritical fluids for enhancing solubility and bioavailability
3.1.12 Dendrimer nanotechnology products for pharmaceuticals
3.1.13 Novel method and formulation of drugs to treat and reduce the spread of respiratory infections
3.1.14 Nanoparticulate formulations for the pharmaceutical and healthcare industries

3.2 PHARMACEUTICALS: DRUG DELIVERY
3.2.1 Nanocrystals for biomedical, photonic and optoelectronic applications
3.2.2 Controlled delivery and stabilization of various pharmacological reagents
3.2.3 Nanoencapsulation for drug delivery
3.2.4 New polymeric nanospheres and applications
3.2.5 Nano-device platform for various encapsulation applications
3.2.6 Responsive nanoparticles for drug delivery
3.2.7 Nanoscale cochleate drug delivery
3.2.8 Nanoencapsulated anti-cancer drugs
3.2.9 Nanoparticle cancer treatment and therapeutic vaccines
3.2.10 Marine extracted nano injectors for delivering drugs into the epidermis skin layer
3.2.11 Nanoscale therapeutic anti-bodies
3.2.12 Nano carriers
3.2.13 Nanocrystals for drug delivery
3.2.14 Drug delivery coatings
3.2.15 Nanocapsules
3.2.16 Characterization of dynamic colloidal structures
3.2.17 Nanocapsulation of different oily and water-soluble substances
3.2.18 New treatments for cancer based on nano and bio
3.2.19 Nanoparticle anti-cancer agents
3.2.20 Nanoencapsulation for delivery of active ingredients
3.2.21 Micro-needle arrays
3.2.22 Nanopores for brachytherapy, inhalation, transdermal and implant delivery methods
3.2.23 Creation of nutritional, clinical nutrition and drug delivery systems based on carbohydrates
3.2.24 Carbon nanotubes for life science applications
3.2.25 Nanoparticle coated microcrystals
3.2.26 Novel chemical method of making hollow spherical silica shells
3.2.27 Stealth particles¡¯ fabricated and coated with surfactants and phosolipids
3.2.28 Controlled release from layered materials
3.2.29 Smart materials for encapsulation
3.2.30 Anti-microbial nanoencapsulation
3.2.31 Nanocomposite controlled release
3.2.32 Colloidal gold nanoparticles for drug delivery

3.3 MEDICAL SUPPLIES AND DEVICES: IMPLANTS
3.3.1 Hydroxyapatite nanoparticles for bone graft substitutes
3.3.2 Stimulation electrodes using nanotechnology
3.3.3 Sol gel coatings for synthetic bone graft substitutes
3.3.4 Implantable life supporting devices using novel biocompatible polymeric materials
3.3.5 Nano-titania implants
3.3.6 Nanocoating of drug eluting stents and orthopaedic implants
3.3.7 Dental implant coated by a nanostructured titanium oxide film
3.3.8 Stetch receptors for prosthesis
3.3.9 Nanocoatings for medical implants
3.3.10 Anti-microbial resistant surfaces for medical implants
3.3.11 Soft tissue nanostructured surface modification
3.3.12 Implants and drug delivery

3.4 MEDICAL SUPPLIES AND DEVICES: COATINGS
3.4.1 Biocompatible nanocoatings
3.4.2 Surface modification solutions for medical devices
3.4.3 Nanoscale plasma coating for medical devices
3.4.4 Light activated anti-microbials
3.4.5 Silver nanoparticle antimicrobial surface treatment for medical devices
3.4.6 Coatings for medical devices
3.4.7 Easy-to-clean hydrophobic coatings
3.4.8 Nanostructured surfaces and textures
3.4.9 Sol-Gel based multifunctional coatings for medical applications
3.4.10 Anti-fouling nanocoatings
3.4.11 Passive, nano-film hydroxyapatite coating for drug-eluding stents
3.4.12 Nanocoatings for surface functionalization
3.4.13 Modification and characterization of polymeric, metallic and ceramic material surfaces
3.4.14 Method for disinfecting small water lines
3.4.15 Non-stick nanoparticulate coating that prevents bacteria and other living cells from
3.4.16 Nanostructured anti-bacterial surfaces
3.4.17 Artificial vascular access grafts

3.5 MEDICAL SUPPLIES AND DEVICES: WOUND CARE
3.5.1 Nanosilver and nanogold gels for anti-microbial burn and wound dressings
3.5.2 Textiles for wound dressing
3.5.3 Antimicrobial nanosilver

3.6 DIAGNOSTICS AND THERAPIES
3.6.1 Nanoemulsions for multimodal molecular imaging and targeted therapeutics
3.6.2 Magnetic nanoparticles for the detection, characterization and treatment of cancer
3.6.3 Nanoparticles with functional properties for biochemical applications
3.6.4 Bioseparation gene transfection and detection systems
3.6.5 Genome sequencing via synthesis of nucleic acids
3.6.6 Magnetic nanoparticles for rare cell isolation
3.6.7 Iron oxide nanoparticles to treat anemia
3.6.8 Therapeutics from its polymeric nanoparticle technology platform
3.6.9 Nanotransponders
3.6.10 Non-invasive medical therapies using patented nanoparticles
3.6.11 Non-invasive product that kills cancer using localized lethal heat
3.6.12 Nanobiosensors
3.6.13 Nanoarray biochips
3.6.14 Medical diagnostic imaging
3.6.15 Immunoassays for automated biochemistry analysers
3.6.16 Smart card diagnostics
3.6.17 Nanosensors and nano biosensors
3.6.18 Silicon-based chips/sensors for pH and pressure
3.6.19 Novel microfluidic technology
3.6.20 Micro- and nano-replication for point-of-use analytical applications
3.6.21 Encapsulation of radioactive nanoparticle for diagnostic and curative purposes
3.6.22 Redox enzymes
3.6.23 Nanocells

3.7 REGENERATIVE MEDICINE
3.7.1 Tissue regeneration and biosensing
3.7.2 Nanostructured hydroxyapatite for tissue engineering
3.7.3 Nanoemulsions capable of targeting and binding to the specific receptors of LDL existing on the surface of cellular membranes
3.7.4 Control of the regeneration of diseased tissue
3.7.5 Self-assembling nanoscale scaffolds
3.7.6 Nano grafting of combinatorial polymer brushes
3.7.7 Tissue engineering products utilising magnetic nanoparticles
3.7.8 Nano wrinkles of scaffolding for controlled cell growth
3.7.9 Fabrication of synthetic biomaterials that induce a cellular response similar to that found in-vivo
3.7.10 Design of new bioactive scaffolds for tissue engineering applications

4 GLOSSARY OF TERMS

ȸ»ç¼Ò°³ | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | ¹è¼Û/°áÁ¦¾È³» | ÀÌ¿ë¾È³»

¼­¿ï½Ã °­³²±¸ ³íÇöµ¿ 210-1 »ï¿øºôµù | ȸ»ç¸í : (ÁÖ)¿¤¾Ø¿¡Ä¡
´ëÇ¥ÀüÈ­ : 02-554-0001 / Æѽº : 02-3444-5501 / À̸ÞÀÏ : sales@landh.co.kr
Copyright ¨Ï 2008 LNH, Inc. All rights reserved.